We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$88.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$80.1M
3
FRPT icon
Freshpet
FRPT
+$60.8M
4
AMZN icon
Amazon
AMZN
+$55.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UI icon
226
Ubiquiti
UI
$34.3B
$372K ﹤0.01%
+3,208
New +$393K
BNRG icon
227
Brenmiller Energy
BNRG
$970K
$366K ﹤0.01%
+1,046
New +$745K
ERIE icon
228
Erie Indemnity
ERIE
$13.2B
$365K ﹤0.01%
+909
New +$334K
URI icon
229
United Rentals
URI
$72.4B
$365K ﹤0.01%
506
+16
+3% +$10.3K
PRGO icon
230
Perrigo
PRGO
$1.78B
$357K ﹤0.01%
+11,104
New +$350K
GOVX icon
231
GeoVax Labs
GOVX
$4.01M
$356K ﹤0.01%
7,120
+2,783
+64% +$220K
YTEN
232
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$352K ﹤0.01%
+38,578
New +$243K
TNL icon
233
Travel + Leisure Co
TNL
$4.7B
$342K ﹤0.01%
+6,995
New +$299K
ROKU icon
234
Roku
ROKU
$22.7B
$328K ﹤0.01%
+5,034
New +$392K
LAD icon
235
Lithia Motors
LAD
$8.26B
$322K ﹤0.01%
+1,069
New +$316K
SNA icon
236
Snap-on
SNA
$21.5B
$316K ﹤0.01%
+1,068
New +$303K
ASNS
237
DELISTED
ACTELIS NETWORKS INC
ASNS
$310K ﹤0.01%
30,100
– –
KMX icon
238
CarMax
KMX
$8.26B
$310K ﹤0.01%
+3,557
New +$269K
RBLX icon
239
Roblox
RBLX
$27B
$306K ﹤0.01%
+8,010
New +$325K
VTAK icon
240
Catheter Precision
VTAK
$1.01M
$302K ﹤0.01%
3,271
+1,991
+156% +$177K
PSX icon
241
Phillips 66
PSX
$81.4B
$295K ﹤0.01%
+1,809
New +$261K
TTWO icon
242
Take-Two Interactive
TTWO
$46.1B
$295K ﹤0.01%
+1,985
New +$308K
GNPX icon
243
Genprex
GNPX
$2.16M
$292K ﹤0.01%
+89
New +$586K
OLOX
244
Olenox Industries
OLOX
$4.5M
$291K ﹤0.01%
+114
New +$486K
PALI icon
245
Palisade Bio
PALI
$367M
$287K ﹤0.01%
+48,000
New +$335K
WK icon
246
Workiva
WK
$3.54B
$285K ﹤0.01%
+3,362
New +$303K
PRFX icon
247
PRF Technologies Ltd
PRFX
$3.16M
$284K ﹤0.01%
1,300
-117
-8% -$29.4K
CHE icon
248
Chemed
CHE
$7.22B
$284K ﹤0.01%
+442
New +$269K
AAL icon
249
American Airlines Group
AAL
$10.6B
$281K ﹤0.01%
+18,331
New +$266K
ORA icon
250
Ormat Technologies
ORA
$6.64B
$280K ﹤0.01%
+4,234
New +$283K
8 9
10
11 12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.